Juvenile interleukin-36 receptor antagonist deficiency (DITRA) with c.80T>C (p.Leu27Pro) mutation successfully treated with etanercept and acitretin
Main Authors: | Edwin Cuperus, MD, Rosanne Koevoets, MD, PhD, Jasper J. van der Smagt, MD, Johan Toonstra, MD, PhD, Marlies de Graaf, MD, PhD, Joost Frenkel, MD, PhD, Suzanne G.M.A. Pasmans, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-03-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512617302047 |
Similar Items
-
Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept
by: Rachel Choi, MD, et al.
Published: (2022-11-01) -
Successful treatment of subcorneal pustular dermatosis targeting an underlying monoclonal IgA gammopathy
by: Ina Kreyberg, MD, PhD, et al.
Published: (2023-11-01) -
Pustular eruption on the palms and soles associated with zinc allergy and perspiration
by: Yukiko Naito, MD, PhD, et al.
Published: (2023-06-01) -
Subcorneal pustular dermatosis as a cause of pityriasis amiantacea in a young child
by: Soo Ran Lee, MD, et al.
Published: (2021-12-01) -
Generalized pustular psoriasis in Brazil: A public claims database studyCapsule Summary
by: Gleison Vieira Duarte, MD, et al.
Published: (2022-03-01)